Targeting Tumor-Infiltrating Macrophages Decreases Tumor-Initiating Cells, Relieves Immunosuppression, and Improves Chemotherapeutic Responses
Jonathan B. Mitchem(The University of Queensland), David G. DeNardo(Washington University in St. Louis), Stephen M. Hewitt(National Institutes of Health), Girish Mallya Udupi(The University of Queensland), Yu Zhu(The University of Queensland), Brian A. Belt(The University of Queensland), Dominic E. Sanford(The University of Queensland), David Piwnica‐Worms(The University of Texas MD Anderson Cancer Center), Lynne Collins(Mallinckrodt (United States)), Donal J. Brennan(Mater Misericordiae University Hospital), Brett L. Knolhoff(The University of Queensland), Peter S. Goedegebuure(The University of Queensland), David C. Linehan(University of Rochester), Larisa Belaygorod(The University of Queensland), Danielle Carpenter(The University of Queensland), Brian L. West(The University of Queensland), William M. Gallagher(University College Dublin), Craig D. Wegner(The University of Queensland), Andrea Wang‐Gillam(Washington University in St. Louis)
Cited by 941
Related Papers
Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma
|Nature|2010|1.8k
Granzyme B and Perforin Are Important for Regulatory T Cell-Mediated Suppression of Tumor Clearance
|Immunity|2007|988
FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis
|The Lancet Oncology|2016|914
CXCR4 Regulates Growth of Both Primary and Metastatic Breast Cancer
|Cancer Research|2004|717